Actively Recruiting
Study of the glUCModel Mobile App for Insulin Dosing and Glucose Prediction in Adults with Type 1 Diabetes Using Multiple Daily Injections
Led by Universidad Complutense de Madrid · Updated on 2026-01-06
34
Participants Needed
2
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety and effectiveness of integrating predictive models into insulin therapy management through the glUCModel mobile app in adults with Type 1 Diabetes Mellitus who are using Multiple Daily Injections MDI therapy. The study focuses on whether using the app improves blood sugar control by increasing the time glucose levels stay within a target range, reducing episodes of high and low blood sugar, and assessing the apps design and usability. The trial is a randomized and open-label study involving participants aged 18 to 65 years. Participants will go through four phases an initial screening phase to collect consent and baseline data a 2-week run-in phase where standard care with continuous glucose monitoring CGM is followed to create personalized models for those in the app group an active treatment phase where all continue MDI therapy with the intervention group additionally using the glUCModel app and a final evaluation phase involving questionnaires and data analysis. CGM data from the last two weeks of treatment will be analyzed to measure outcomes. During the study, participants will complete questionnaires assessing treatment satisfaction and usability, including the Pittsburgh and DTSQ surveys. Researchers will monitor blood sugar levels, counting the frequency and duration of hypo- and hyperglycemic events, glycemic variability, and adherence to app recommendations. The primary outcome is the percentage of time spent in the target glucose range during the last two weeks. The total participation spans from screening through data evaluation, with safety and usability closely monitored throughout.
CONDITIONS
Brief Title
Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol
Research Team
I
Ignacio Hidalgo, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here